As of April 2025, four CD19-directed chimeric antigen receptor (CAR)-T therapies and three CD20-targeting bispecific antibodies (BsAbs) have been US Food and Drug Administration (FDA) approved for the ...

READING, Pa. – During its Committee of the Whole meeting Monday night, Reading City Council heard an update presentation from Simone Collins Landscape Architecture, Norristown, on transit-oriented ...